JP2013540826A5 - - Google Patents

Download PDF

Info

Publication number
JP2013540826A5
JP2013540826A5 JP2013536904A JP2013536904A JP2013540826A5 JP 2013540826 A5 JP2013540826 A5 JP 2013540826A5 JP 2013536904 A JP2013536904 A JP 2013536904A JP 2013536904 A JP2013536904 A JP 2013536904A JP 2013540826 A5 JP2013540826 A5 JP 2013540826A5
Authority
JP
Japan
Prior art keywords
formulated
administration
crofelemer
daily
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013536904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013540826A (ja
JP6063385B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/058549 external-priority patent/WO2012058664A1/en
Publication of JP2013540826A publication Critical patent/JP2013540826A/ja
Publication of JP2013540826A5 publication Critical patent/JP2013540826A5/ja
Application granted granted Critical
Publication of JP6063385B2 publication Critical patent/JP6063385B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013536904A 2010-10-31 2011-10-31 Hiv関連の下痢を治療するための方法および組成物 Active JP6063385B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US61/408,622 2010-10-31
US40933510P 2010-11-02 2010-11-02
US61/409,335 2010-11-02
US41624910P 2010-11-22 2010-11-22
US61/416,249 2010-11-22
US201161434379P 2011-01-19 2011-01-19
US61/434,379 2011-01-19
PCT/US2011/058549 WO2012058664A1 (en) 2010-10-31 2011-10-31 Methods and compositions for treating hiv-associated diarrhea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016151656A Division JP6310971B2 (ja) 2010-10-31 2016-08-02 Hiv関連の下痢を治療するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2013540826A JP2013540826A (ja) 2013-11-07
JP2013540826A5 true JP2013540826A5 (cg-RX-API-DMAC7.html) 2014-12-18
JP6063385B2 JP6063385B2 (ja) 2017-01-18

Family

ID=45994461

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013536904A Active JP6063385B2 (ja) 2010-10-31 2011-10-31 Hiv関連の下痢を治療するための方法および組成物
JP2016151656A Active JP6310971B2 (ja) 2010-10-31 2016-08-02 Hiv関連の下痢を治療するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016151656A Active JP6310971B2 (ja) 2010-10-31 2016-08-02 Hiv関連の下痢を治療するための方法および組成物

Country Status (20)

Country Link
US (4) US8962680B2 (cg-RX-API-DMAC7.html)
EP (1) EP2632550B1 (cg-RX-API-DMAC7.html)
JP (2) JP6063385B2 (cg-RX-API-DMAC7.html)
CN (2) CN107595836A (cg-RX-API-DMAC7.html)
AU (1) AU2011320155B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013010774A2 (cg-RX-API-DMAC7.html)
CA (1) CA2816416C (cg-RX-API-DMAC7.html)
DK (1) DK2632550T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP13012650A (cg-RX-API-DMAC7.html)
ES (1) ES2635435T3 (cg-RX-API-DMAC7.html)
HK (1) HK1249036A1 (cg-RX-API-DMAC7.html)
HU (1) HUE035393T2 (cg-RX-API-DMAC7.html)
MX (1) MX348184B (cg-RX-API-DMAC7.html)
PE (1) PE20140036A1 (cg-RX-API-DMAC7.html)
PH (1) PH12013500857A1 (cg-RX-API-DMAC7.html)
PL (1) PL2632550T3 (cg-RX-API-DMAC7.html)
PT (1) PT2632550T (cg-RX-API-DMAC7.html)
RU (1) RU2597746C2 (cg-RX-API-DMAC7.html)
WO (1) WO2012058664A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201303136B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
EP2015639A4 (en) 2006-05-01 2009-11-25 Napo Pharmaceuticals Inc METHOD FOR TREATING CONSTITUTIONAL PREDOMINANT IRRITATION SYNDROME
WO2007130893A2 (en) * 2006-05-01 2007-11-15 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
HUE035393T2 (en) 2010-10-31 2018-05-02 Napo Pharmaceuticals Inc Procedures and preparations for the treatment of HIV-related diarrhea
US20140163096A1 (en) * 2012-12-07 2014-06-12 Pam Golden Methods and compositions for treating hiv-associated diarrhea
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
JOP20220339A1 (ar) * 2020-06-19 2023-01-30 Napo Pharmaceuticals Inc طرق وتركيبات علاج الإسهال الناتج عن العلاج الكيميائي
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
EP2255661A3 (en) 1996-10-16 2010-12-22 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
US20080025966A1 (en) * 2004-01-30 2008-01-31 Currie Mark G Methods And Compositions For The Treatment Of Gastrointestinal disorders
EP1937655A1 (en) * 2005-06-22 2008-07-02 University of Massachusetts Hiv-1 protease inhibitors, and methods of making and using them
JP2009524585A (ja) 2005-12-15 2009-07-02 バイエル・ヘルスケア・アクチェンゲゼルシャフト ウイルス感染を処置するためのジアリールウレア
EP2015639A4 (en) * 2006-05-01 2009-11-25 Napo Pharmaceuticals Inc METHOD FOR TREATING CONSTITUTIONAL PREDOMINANT IRRITATION SYNDROME
WO2007130893A2 (en) 2006-05-01 2007-11-15 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
PH12012500557A1 (en) 2009-08-26 2012-10-22 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
CA2777214A1 (en) * 2009-10-06 2011-04-14 The Regents Of The University Of California Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
HUE035393T2 (en) 2010-10-31 2018-05-02 Napo Pharmaceuticals Inc Procedures and preparations for the treatment of HIV-related diarrhea
BR112013018688B1 (pt) 2011-01-27 2021-08-24 Napo Pharmaceuticals, Inc Método de produção de uma composição polimérica de proantocianidina
MX2014007635A (es) 2011-12-22 2014-09-22 Glenmark Pharmaceuticals Ltd Composicion farmaceutica no enterica que comprende crofelemer.
US20140163096A1 (en) 2012-12-07 2014-06-12 Pam Golden Methods and compositions for treating hiv-associated diarrhea

Similar Documents

Publication Publication Date Title
JP2013540826A5 (cg-RX-API-DMAC7.html)
Giannaki et al. Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review
Tobin et al. New psychotherapeutic agent, chlordiazepoxide: Use in treatment of anxiety states and related symptoms
Gamit et al. The effect of stretching exercise on primary dysmenorrhea in adult girls
RU2013123794A (ru) Способы и композиции для лечения вич-ассоциированной диареи
HRP20241454T1 (hr) Migalastat za upotrebu u postupcima liječenja fabrijeve bolesti kod pacijenata koji imaju mutaciju u gla genu
RU2009119258A (ru) Способ лечения воспалительных заболеваний кишечника
UA111480C2 (uk) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ЛІКУВАННЯ СИНДРОМУ ПОДРАЗНЕНОГО КИШЕЧНИКУ, ЯКА ВВОДИТЬСЯ ПЕРОРАЛЬНО, ЩО МІСТИТЬ ТРИМЕБУТИН, СИМЕТИКОН, α-D-ГАЛАКТОЗИДАЗУ, І СПОСІБ ЇЇ ОТРИМАННЯ
CN104257790B (zh) 一种复方枣仁胶囊的新用途
Widjanarko et al. Laxative potential of the konjac flour (Amorphophallus muelleri Blume) in treatment of loperamide induced constipation on Sprague Dawley rats
RU2476140C1 (ru) Способ выявления психопатологической природы сексуального расстройства у женщин с хроническим сальпингоофоритом
Vasileva Bruxism-description, epidemiology, etiology, classification
Chen et al. Systemic tacrolimus in the treatment of recalcitrant mucosal lichen planus
Richter A randomized trial of pessary vs. behavioral therapy vs. combined therapy for treatment of stress urinary incontinence
Chee et al. Pityriasis rubra pilaris: Not just skin deep a case series
UA112652C2 (uk) Фармацевтична композиція для лікування передчасної еякуляції і спосіб лікування передчасної еякуляції
CN102688402A (zh) 一种治疗肝硬化肝腹水的药物
CN102416043B (zh) 一种治疗小儿脾虚腹泻的中药
Nevagi et al. International Journal for Empirical Research in Ayurveda
Zouhri et al. Covid-19 with neuropathic pain symptom: A case-report
Khan et al. Effects of diuretics and vasodilators therapy in Meniere’s disease
Ghuse et al. Shashtika Shali Pinda Sweda in the Management of Child Cerebral Palsy Spasticity
Lamina et al. Shortwave diathermy in the management of chronic pelvic inflammatory disease pain
CN106727952A (zh) 一种治疗牙痛的药物组合物
Rosenberg Electroacupuncture is beneficial in women with stress incontinence